Tags Archive Navigation
icon
-
Media ReleaseNovartis pledges 10-year commitment with Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools and other leading organizations to co-create effective, measurable solutions for health equity
-
Media ReleaseNovartis accelerates efforts toward ESG targets to increase access to medicines, improve health equity and achieve net-zero carbon emissions
-
Media ReleaseNovartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond
-
Media ReleaseNovartis set to achieve 100% renewable electricity in its European operations
-
Media ReleaseNovartis renews WHO medicine donation pledge with aim of ending leprosy
-
Media ReleaseNovartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine
-
Media ReleaseNovartis announces broad range of initiatives to respond to COVID-19 Pandemic; Creates USD 20 million global fund to support impacted communities
-
Media ReleaseNovartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
-
Media ReleaseNovartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
-
Media ReleaseNovartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program
-
Media ReleaseNovartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients
-
Media ReleaseNovartis Resolves Legacy FCPA Investigations